PMID: 2503916May 1, 1989Paper

Toxicity of microcystin LR, a cyclic heptapeptide hepatotoxin from Microcystis aeruginosa, to rats and mice

Veterinary Pathology
S B HooserW M Haschek

Abstract

Rats (Sprague-Dawley) and mice (Balb/c) were given microcystin LR intraperitoneally and were killed at intervals up to 24 hr (rats) or 90 min (mice) and necropsied. The lowest consistently lethal dose was 160 micrograms/kg in rats and 100 micrograms/kg in mice. Rats that were clinically unaffected had no lesion. All clinically affected rats in all dose groups died (from 20 to 32 hr after toxin) and had similar hepatic lesions. Livers were enlarged and dark red beginning 40 to 60 min after toxin. Mild disassociation and rounding of centrilobular hepatocytes developed within 20 min. By 60 min after toxin, degeneration and necrosis of hepatocytes involved most of the lobules except for small periportal zones. Weights of livers and kidneys were significantly increased. Eosinophilic fibrillar material filled renal glomerular capillaries as early as 9 hr after toxin. At 18 to 24 hr there was moderate vacuolation of proximal tubular epithelium with mild tubular dilatation. Beginning at 1 hr, intact hepatocytes and hepatic debris were present in pulmonary vessels. Analysis of serum revealed an increase in alanine aminotransferase 40 min after toxin; at 6 to 12 hr there were significant increases in alkaline phosphatase, total bilirubin...Continue Reading

References

Jun 1, 1978·Australian Journal of Biological Sciences·T C EllemanM T Runnegar
Jan 1, 1986·Toxicon : Official Journal of the International Society on Toxinology·M T Runnegar, I R Falconer
Aug 1, 1986·Environmental Research·S Oishi, M F Watanabe
Jan 1, 1985·Toxicon : Official Journal of the International Society on Toxinology·W H AdamsH W Siegelman
May 28, 1983·The Medical Journal of Australia·I R FalconerM T Runnegar
Jun 24, 1983·Science·D N SlatkinH W Siegelman
Nov 1, 1981·Naunyn-Schmiedeberg's Archives of Pharmacology·M T RunnegarJ Silver

❮ Previous
Next ❯

Citations

Jul 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D M ToivolaJ E Eriksson
Mar 14, 2003·Environmental Toxicology·Michelle M GehringerTimothy G Downing
Jun 11, 1990·Biochimica Et Biophysica Acta·J E ErikssonJ A Meriluoto
Jan 1, 1990·Toxicon : Official Journal of the International Society on Toxinology·J A MeriluotoJ E Eriksson
Jan 1, 1991·Toxicon : Official Journal of the International Society on Toxinology·M T RunnegarI R Falconer
Jan 1, 1991·Toxicon : Official Journal of the International Society on Toxinology·S B HooserW M Haschek
Jan 1, 1991·Toxicon : Official Journal of the International Society on Toxinology·G A MiuraJ G Pace
Jun 1, 1993·Toxicon : Official Journal of the International Society on Toxinology·R R StottsV R Beasley
Feb 1, 1995·Toxicon : Official Journal of the International Society on Toxinology·D E WilliamsC F Holmes
May 1, 1996·Toxicon : Official Journal of the International Society on Toxinology·B G KotakR W Coppock
Jan 7, 2004·Mutation Research·Li ZhanMasamitsu Honma
Sep 9, 2000·Toxicon : Official Journal of the International Society on Toxinology·E ItoK Harada
Nov 10, 2000·Toxicon : Official Journal of the International Society on Toxinology·A C NobreH S Monteiro
Dec 7, 2002·Toxicon : Official Journal of the International Society on Toxinology·Bojana ZeguraMetka Filipic
Jun 5, 2003·Toxicon : Official Journal of the International Society on Toxinology·Roberto E GuzmanMaria T Runnegar
Oct 16, 2003·Toxicon : Official Journal of the International Society on Toxinology·Aleksandra MilutinovićDusan Suput
Jun 1, 1997·Toxicon : Official Journal of the International Society on Toxinology·R R StottsV R Beasley
Feb 11, 2000·Toxicon : Official Journal of the International Society on Toxinology·E ItoK Harada
Aug 1, 1999·Toxicology in Vitro : an International Journal Published in Association with BIBRA·D M Toivola, J E Eriksson
Jun 5, 2003·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Christelle MalbrouckPatrick Kestemont
Sep 11, 2003·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·G L L PinhoJ M Monserrat
Sep 1, 1990·Journal of Toxicology and Environmental Health·S J HermanskyW J Murray
Apr 1, 1995·Pharmacology & Toxicology·O TakahashiM F Watanabe
Mar 4, 2000·Environmental Health Perspectives·B C HitzfeldD R Dietrich
Jul 31, 2013·PloS One·Elizabeth D HilbornSandra M F O Azevedo
Mar 7, 2014·Toxicon : Official Journal of the International Society on Toxinology·Amber F Roegner, Birgit Puschner
Jan 2, 2010·Toxicon : Official Journal of the International Society on Toxinology·Susanna A WoodKen G Ryan
Apr 28, 2012·Journal of Applied Toxicology : JAT·Xin ZhangYan Cai
Apr 24, 2012·The FEBS Journal·David L Brautigan
Sep 17, 2013·Journal of Applied Toxicology : JAT·Amber F RoegnerBirgit Puschner
Jun 18, 2011·Toxicon : Official Journal of the International Society on Toxinology·Natália V CasquilhoWalter A Zin
Mar 1, 2005·Toxicon : Official Journal of the International Society on Toxinology·I MorenoA M Cameán
Mar 2, 2005·Toxicology and Applied Pharmacology·W J FischerB Hagenbuch
Jul 9, 2013·Toxicon : Official Journal of the International Society on Toxinology·Miroslava PalikovaRadovan Kopp
Jun 20, 2015·BMC Veterinary Research·Adrienne C BautistaBirgit Puschner
May 20, 2015·Toxicon : Official Journal of the International Society on Toxinology·Mi ZhouJin Xu
Sep 27, 2012·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Carina MenezesPaulo Pereira
Sep 1, 1991·Japanese Journal of Cancer Research : Gann·R Nishiwaki-MatsushimaH Fujiki
Sep 10, 2016·Journal of Veterinary Internal Medicine·N S MittelmanA L Johnson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.